William Sikov MD
Breast Cancer
Breast Medical Oncology, Professor of Medicine, Obstetrics and Gynecology, Warren Alpert Medical School of Brown University
Join to View Full Profile
Breast Health Center101 Dudley St.Providence, RI 02905
Phone+1 401-453-7540
Fax+1 401-453-7785
Dr. Sikov is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- William Sikov, MD, is a breast medical oncology specialist based in Providence, RI. He has subspecialties in advanced and early-stage breast cancer and clinical trials. Dr. Sikov completed his medical education at Yale School of Medicine in 1982, followed by a residency at UPMC Medical Education from 1982 to 1985. He further pursued his specialty by completing a fellowship in Hematology and Medical Oncology at Tufts Medical Center from 1986 to 1989.
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1986 - 1989
UPMC Medical EducationResidency, 1982 - 1985
Yale School of MedicineClass of 1982
Certifications & Licensure
RI State Medical License 1989 - 2026
MA State Medical License 1986 - 2025
PA State Medical License 1983 - 1990
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Prognostic and molecular multi-platform analysis of CALGB 40603 (Alliance) and public triple-negative breast cancer datasets.Brooke M Felsheim, Aranzazu Fernandez-Martinez, Cheng Fan, Adam D Pfefferle, Michele C Hayward
NPJ Breast Cancer. 2025-03-08 - Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.Karen L Smith, Fengmin Zhao, Ingrid A Mayer, Amye J Tevaarwerk, Sofia F Garcia
Cancer. 2024-05-15 - 21 citationsAKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers.Maysa M Abu-Khalaf, K Alex Hodge, Christos Hatzis, Elisa Baldelli, Emna El Gazzah
NPJ Precision Oncology. 2023-02-16
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
